Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab

Clicks: 276
ID: 95337
2020
Reference Key
fujita2020prognosticoncology Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Fujita, N.
Journal oncology (switzerland)
Year 2020
DOI 10.1159/000502910
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.